AzTrials
AzTrials

Prospective StudyAPART-LUNGNCT07380815

Physical Activity During Radiation Therapy for Lung Cancer

An observational study of Prospective Study, run by University Hospital Schleswig-Holstein at 7 sites in 4 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The primary objective of this trial is to evaluate patterns of physical activity during radiation therapy for lung cancer and to estimate the within-patient change in physical activity between Week 1 and Week 5 of radiation therapy, measured by smart phone-recorded step counts normalized for device carrying time. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Prospective Study
How many people
20 participants
Where
7 sitesin 4 countries
Study dates
1 Feb 2026to 21 May 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients who received conventionally fractionated radiation therapy for lung cancer.

Who may be able to join

  • Histologically proven lung cancer
  • Treatment with ≥50 Gy of conventionally fractionated radiation therapy
  • Possession of and ability to use a smart phone plus a step counter
  • Age ≥18 years
  • Written informed consent
  • Capacity of the patient to consent

Who cannot join

  • 1. Expected Non-Compliance

Trial locations and contacts

7 sites in 4 countries.

7 sites in 4 countries

Germany4 sites
  • MVZ RON Niedersachsen Strahlentherapie GmbH

    Hanover, Lower Saxony, 30161

  • Department of Radiation Oncology, Christian-Albrechts University

    Kiel, Schleswig-Holstein, 24105

  • Department of Pulmonology, University of Luebeck

    Lübeck, Schleswig-Holstein, 23562

  • Department of Radiation Oncology, University of Luebeck

    Lübeck, Schleswig-Holstein, 23562

Other trials in Germany

Denmark1 site
  • Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark

    Vejle, 7100

Other trials in Denmark

Georgia1 site
  • Radiation Oncology Department, Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic

    Tbilisi, 0177

Other trials in Georgia

Slovenia1 site
  • Department of Radiotherapy, Institute of Oncology Ljubljana and Faculty of Medicine, University of Ljubljana

    Ljubljana, 1000

Other trials in Slovenia

About this study

Official title: Assessment of Physical Activity During Radiation Therapy for LUNG Cancer

The primary objective of this trial is to evaluate patterns of physical activity during radiation therapy for lung cancer and to estimate the within-patient change in physical activity between Week 1 and Week 5 of radiation therapy, measured by smart phone-recorded step counts normalized for device carrying time. The trial is exploratory in nature with the aim to generate scientific hypotheses to be investigated in future clinical trials.

Read the detailed description

Lung cancer belongs to the most common types of solid cancer in Europe and Northern America. A considerable number of patients with lung cancer receive conventionally fractionated radiation therapy with or without systemic treatment. Radiation therapy may be associated with adverse events affecting healthy tissues within the radiation field but also with fatigue and a decreased level of physical activity or function. Patients who experience significant treatment-related toxicity may not be able to receive the complete radiation therapy as planned. Maintaining or even improving the level of activity by physical exercise or walking a certain number of steps per day may be helpful in this context. A benefit of exercise has been suggested in a retrospective study of 184 cancer patients receiving neoadjuvant chemotherapy, including 31 patients with lung cancer. Adherence to an exercise program was associated with fewer dose reductions and delays of chemotherapy. Moreover, several studies performed in patients with lung cancer suggested that physical activity had a positive effect on the patient's quality of live. Thus, physical activity prior to and during chemo- and/or immunotherapy for lung cancer appears important. This may also be true for patients with lung cancer treated with radiation therapy. However, adherence to an exercise program sometimes may be challenging for the patients, particularly if they experience treatment-related fatigue or other adverse events. The question arose whether an easy-to-use mobile app installed on the patient's smart phone reminding patients several times daily to perform a certain number of steps will have a positive effect on their physical activity during a course of radiation therapy. Such an app is planned to be tested in a prospective trial. However, step counts derived from smart phones are influenced by variability in device carrying time, as patients may not carry their phones consistently throughout the day. This variability introduces measurement heterogeneity that must be explicitly addressed in the statistical design and analysis. The present study is designed as a pilot investigation for this prospective trial to evaluate changes in physical activity during radiation therapy while establishing a robust and Good Clinical Practice (GCP)-compliant analytical framework for smart phone-derived step data. Physical activity is assessed during Week 1 and Week 5 of radiation therapy using a smart phone application. A total of approximately 20 patients qualifying for the Full Analysis Set are planned to be enrolled and documented. Recruitment of all patients should be completed within 3 months. This period also represents the total running time for this study. The study is designed as a pilot and feasibility investigation and is not intended to provide confirmatory evidence.

Keywords
lung cancer, radiation therapy, physical activity
Medical subject headings
Lung Neoplasms, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07380815
Study groupRoleWhat they receive
Patients with steps counted by their smart phoneThe purpose is to obtain a patient's mean number of steps per week during week 1 and week 5 of a radiation therapy course for lung cancer directly from the patient's smart phone which has a step counter.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mean number of steps per week during week 1 and week 5 of radiation therapy for lung cancer

    The primary endpoint is to assess the within-patient difference in weekly average steps per wear-hour of the smart phone (Week 5 minus Week 1 of radiation therapy). Any type of smart phone is allowed, as long as it has a step counter.

    Measured: through study completion, 5 weeks

Secondary outcomes (1)
  1. Wear-time of the smart phone

    The mean wear-time of the smart phone per day (given in hours) during week 1 and week 5 of the radiation therapy course is assessed.

    Measured: through study completion, 5 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Feb 2026
  2. Study start1 Feb 2026
  3. Primary completion27 Apr 2026
  4. Study completion21 May 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07380815
Sponsor's protocol ID
APART-LUNG
Acronym
APART-LUNG
Status last verified
May 2026
First submitted
25 Jan 2026
Last updated
2 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Prospective Study, run by University Hospital Schleswig-Holstein at 7 sites in 4 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 7 sites in Germany, Denmark, Georgia, Slovenia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mean number of steps per week during week 1 and week 5 of radiation therapy for lung cancer (time frame: through study completion, 5 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jun 2026; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in